Although future functional studies are required to elucidate the underlying biological processes, one possible explanation could be an increased EPCR expression and/or activity paralleling with PC trapping by EPCR, thus impairing the anticoagulation pathway while promoting cancer progression through coagulation-independent mechanisms in individuals without symptomatic VTE. This evidence concerns the gene PROCR and cancer.